These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4115268)

  • 1. [Indications for and hazards of immunosuppressive therapy].
    Löffler H
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:358-63. PubMed ID: 4115268
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive therapy in rheumatology (comprehensive review)].
    Hàndlovà D
    Fysiatr Revmatol Vestn; 1973 Aug; 51(4):238-44. PubMed ID: 4581166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic treatment of autoimmune diseases].
    Gjone E
    Tidsskr Nor Laegeforen; 1969 Mar; 89(6):387-90. PubMed ID: 5792114
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclosporin A in inflammatory rheumatic diseases].
    Gross WL; Rob PM
    Internist (Berl); 1996 Jan; 37(1):91-7. PubMed ID: 8837835
    [No Abstract]   [Full Text] [Related]  

  • 5. Antitumor drug toxicity: implications for response and for survival.
    Nahhas WA; Hall TC; Sherman CD; Savlov ED
    Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of immunosuppressive drugs].
    Dimitriu CG; Zeana C
    Med Interna (Bucur); 1972 Aug; 24(8):977-83. PubMed ID: 5080894
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive therapy].
    Schumacher K; Gross R
    Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
    [No Abstract]   [Full Text] [Related]  

  • 8. [The immunosuppressive agents in rheumatology].
    Dorfamnn H; Dreyfus P
    Minerva Med; 1969 Nov; 60(94):4711-4. PubMed ID: 5307890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bases of immunosuppression and immunostimulation including their side effects in immunopathological diseases].
    Deicher H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():773-82. PubMed ID: 612054
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
    Kahn MF; De Seze S
    Ann Med Interne (Paris); 1974; 125(6-7):497-506. PubMed ID: 4216281
    [No Abstract]   [Full Text] [Related]  

  • 11. Selected problems in immunosuppressive therapy.
    Rondio H
    Mater Med Pol; 1974; 6(1):34-40. PubMed ID: 4613962
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacology of immunosuppressive agents.
    Mitchell MS; Bertino JR
    Conn Med; 1970 Dec; 34(12):843-50. PubMed ID: 4923392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experience with immunosuppressive therapy in internal medicine].
    Rhomberg F; Siegenthaler W
    Schweiz Med Wochenschr; 1967 Feb; 97(8):255-9. PubMed ID: 5598379
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunodepressive methods used in clinical medicine].
    Frei PC
    Rev Med Suisse Romande; 1974 Sep; 94(9):711-21. PubMed ID: 4548210
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of cytotoxic drugs during pregnancy.
    Ramsey-Goldman R
    Scand J Rheumatol Suppl; 1998; 107():133-5. PubMed ID: 9759152
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is certain in the treatment with immunosuppressive agents?].
    Malchow H
    Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunosuppressive agents].
    Czarnecka E; Staszewski J
    Wiad Lek; 1970 May; 23(10):821-5. PubMed ID: 4912992
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of progressive chronic polyarthritis].
    Rau R
    Ther Umsch; 1972 Aug; 29(8):462-80. PubMed ID: 5055046
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.